Objective To determine whether diabetes prevalence and incidence has remained flat or changed direction during the past 5 years. Research design and methods We calculated annual prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined) for civilian, non-institutionalized adults aged 18–79 years using annual, nationally representative cross-sectional survey data from the National Health Interview Survey from 1980 to 2017. Trends in rates by age group, sex, race/ethnicity, and education were calculated using annual percentage change (APC). Results Overall, the prevalence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.4%) from 1990 to 2009 to a peak of 8....
An observational cohort analysis was conducted within the Surveillance, Prevention, and Management o...
One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-sta...
Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
OBJECTIVE To examine the age-specific changes of prevalence of diabetes among U.S. adults during the...
Objective To assess what proportions of studies reported increasing, stable, or declining trends in ...
OBJECTIVEdTo examine the age-specific changes of prevalence of diabetes among U.S. adults during the...
The maps show the trend in age\ue2\u20ac\u201cadjusted prevalence of diagnosed diabetes among adults...
OBJECTIVE — To project the number of people with diagnosed diabetes in the U.S. through 2050, accoun...
OBJECTIVEdTo examine the age-specific changes of prevalence of diabetes among U.S. adults during the...
Background In recent decades, the United States experienced increasing prevalence and incidence of d...
The maps show the trend in age\ue2\u20ac\u201cadjusted prevalence of diagnosed diabetes among adults...
Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchan...
Objective To examine recent trends in type 2 diabetes detection among adults in the USA. Research de...
Objective. We conducted a systematic review to assess what proportions of studies reported increasin...
Number and percentage of the U.S. population with diagnosed diabetes were obtained from the National...
An observational cohort analysis was conducted within the Surveillance, Prevention, and Management o...
One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-sta...
Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...
OBJECTIVE To examine the age-specific changes of prevalence of diabetes among U.S. adults during the...
Objective To assess what proportions of studies reported increasing, stable, or declining trends in ...
OBJECTIVEdTo examine the age-specific changes of prevalence of diabetes among U.S. adults during the...
The maps show the trend in age\ue2\u20ac\u201cadjusted prevalence of diagnosed diabetes among adults...
OBJECTIVE — To project the number of people with diagnosed diabetes in the U.S. through 2050, accoun...
OBJECTIVEdTo examine the age-specific changes of prevalence of diabetes among U.S. adults during the...
Background In recent decades, the United States experienced increasing prevalence and incidence of d...
The maps show the trend in age\ue2\u20ac\u201cadjusted prevalence of diagnosed diabetes among adults...
Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchan...
Objective To examine recent trends in type 2 diabetes detection among adults in the USA. Research de...
Objective. We conducted a systematic review to assess what proportions of studies reported increasin...
Number and percentage of the U.S. population with diagnosed diabetes were obtained from the National...
An observational cohort analysis was conducted within the Surveillance, Prevention, and Management o...
One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age-sta...
Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in...